Risk during Pregnancy and Birth after Assisted Reproductive Technologies: An Integral View of the Problem

ABSTRACT

Pregnancy and obstetric outcome are the final steps in infertility treatment. Additional data from recent studies demonstrate an increased risk for pregnancy course and obstetric outcome. These risks include an increased risk for intrauterine growth retardation, preeclampsia, and premature birth. Children born after in vitro fertilization and intracytoplasmic sperm injection (ICSI) have an increased risk for major malformations compared with spontaneously conceived pregnancies. Patients have to be counseled about these risks. The question is where these increased risks originate. At present, there are insufficient data available from pregnancies established following hormonal treatment or intrauterine insemination cycles. Therefore, the question is still open for debate, whether either in vitro culture or infertility per se or perhaps other components of the treatment cycle contribute to this risk. There is some evidence that at least the ICSI technique or the in vitro culture technique is not the only or most prominent factor. A long time to pregnancy with subsequent spontaneous pregnancy results in a similar risk profile as pregnancies following infertility treatment. This article discusses a possible pathogenetic model for these observations.

KEYWORDS

IVF - ICSI - pregnancy - malformation - imprinting defect

REFERENCES

• 1 Bonduelle M, Liebaers I, Deketelaere V et al.. Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999).  Hum Reprod. 2002;  17 671-694
• 2 Hansen M, Kurinczuk J J, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization.  N Engl J Med. 2002;  346 725-730
• 3 Katalinic A, Rösch C, Ludwig M. for German ICSI Follow-Up Study Group . Pregnancy course and outcome after intracytoplasmic sperm injection (ICSI)-a controlled, prospective cohort study.  Fertil Steril. 2004;  81 1604-1616
• 4 Ludwig M, Katalinic A. Malformation rate in fetuses and children conceived after intracytoplasmic sperm injection (ICSI): results of a prospective cohort study.  Reprod Biomed Online. 2002;  5 171-178
• 5 Ludwig M, Diedrich K. Follow up of children born after assisted reproductive technologies.  Reprod Biomed Online. 2002;  5 317-322
• 6 Ludwig M, Katalinic A. Pregnancy course and health of children born after ICSI depending on parameters of male factor infertility.  Hum Reprod. 2003;  18 351-357
• 7 Ericson A, Kallen B. Congenital malformations in infants born after IVF: a population-based study.  Hum Reprod. 2001;  16 504-509
• 8 Wennerholm U B, Bergh C, Hamberger L et al.. Incidence of congenital malformations in children born after ICSI.  Hum Reprod. 2000;  15 944-948
• 9 Edwards R G, Ludwig M. Are major defects in children conceived in vitro due to innate problems in patients or to induced genetic damage?.  Reprod Biomed Online. 2003;  7 131-138
• 10 Gosden R, Trasler J, Lucifero D, Faddy M. Rare congenital disorders, imprinted genes, and assisted reproductive technology.  Lancet. 2003;  361 1975-1977
• 11 Hoshi H. In vitro production of bovine embryos and their application for embryo transfer.  Theriogenology. 2003;  59 675-685
• 12 Sollars V, Lu X, Xiao L, Wang X, Garfinkel M D, Ruden D M. Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution.  Nat Genet. 2003;  33 70-74
• 13 Marques C J, Carvalho F, Sousa M, Barros A. Genomic imprinting in disruptive spermatogenesis.  Lancet. 2004;  363 1700-1702
• 14 Ludwig M. Pregnancy and Birth after Assisted Reproductive Technologies. Berlin; Springer Verlag 2002
• 15 Pezeshki K, Feldman J, Stein D E, Lobel S M, Grazi R V. Bleeding and spontaneous abortion after therapy for infertility.  Fertil Steril. 2000;  74 504-508
• 16 Wang J X, Norman R J, Wilcox A J. Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology.  Hum Reprod. 2004;  19 272-277
• 17 Helmerhorst F M, Perquin D A, Donker D, Keirse M J. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies.  BMJ. 2004;  328 261
• 18 Schieve L A, Meikle S F, Ferre C, Peterson H B, Jeng G, Wilcox L S. Low and very low birth weight in infants conceived with use of assisted reproductive technology.  N Engl J Med. 2002;  346 731-737
• 19 Wang J X, Knottnerus A-M, Schuit G, Norman R J, Chan A, Dekker G A. Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia.  Lancet. 2002;  359 673-674
• 20 Vernaeve V, Bonduelle M, Tournaye H, Camus M, Van Steirteghem A, Devroey P. Pregnancy outcome and neonatal data of children born after ICSI using testicular sperm in obstructive and non-obstructive azoospermia.  Hum Reprod. 2003;  18 2093-2097
• 21 Pandian Z, Bhattacharya S, Templeton A. Review of unexplained infertility and obstetric outcome: a 10 year review.  Hum Reprod. 2001;  16 2593-2597
• 22 Basso O, Weinberg C R, Baird D D, Wilcox A J, Olsen J. Subfecundity as a correlate of preeclampsia: a study within the Danish National Birth Cohort.  Am J Epidemiol. 2003;  157 195-202
• 23 Henriksen T B, Baird D D, Olsen J, Hedegaard M, Secher N J, Wilcox A J. Time to pregnancy and preterm delivery.  Obstet Gynecol. 1997;  89 594-599
• 24 Peschka B, Leygraaf J. van d V, Montag M, Schartmann B, Schubert R, Schwanitz G. Type and frequency of chromosome aberrations in 781 couples undergoing intracytoplasmic sperm injection.  Hum Reprod. 1999;  14 2257-2263
• 25 Meschede D, Lemcke B, Exeler J R et al.. Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection-prevalence, types, sex distribution and reproductive relevance.  Hum Reprod. 1998;  13 576-582
• 26 Scholtes M C, Behrend C, Dietzel-Dahmen J et al.. Chromosomal aberrations in couples undergoing intracytoplasmic sperm injection: influence on implantation and ongoing pregnancy rates.  Fertil Steril. 1998;  70 933-937
• 27 Wu L, de Bruin A, Saavedra H I et al.. Extra-embryonic function of Rb is essential for embryonic development and viability.  Nature. 2003;  421 942-947
• 28 Georgiades P, Watkins M, Surani M A, Ferguson-Smith A C. Parental origin-specific developmental defects in mice with uniparental disomy for chromosome 12.  Development. 2000;  127 4719-4728
• 29 Muller F, Dreux S, Lemeur A et al.. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.  Prenat Diagn. 2003;  23 1073-1076
• 30 Ghisoni L, Ferrazzi E, Castagna C, Levi Setti P E, Masini A C, Pigni A. Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients.  Placenta. 2003;  24(suppl B) S99-S103
• 31 Hui P W, Lam Y H, Tang M H, Ng E H, Yeung W S, Ho P C. Amniotic fluid human chorionic gonadotrophin and alpha-fetoprotein levels in pregnancies conceived after assisted reproduction.  Prenat Diagn. 2003;  23 484-487
• 32 Maymon R, Shulman A. Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons.  Hum Reprod. 2002;  17 1081-1085
• 33 Wojdemann K R, Larsen S O, Shalmi A, Sundberg K, Christiansen M, Tabor A. First trimester screening for Down syndrome and assisted reproduction: no basis for concern.  Prenat Diagn. 2001;  21 563-565
• 34 Liao A W, Heath V, Kametas N, Spencer K, Nicolaides K H. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction.  Hum Reprod. 2001;  16 1501-1504
• 35 Wald N J, White N, Morris J K, Huttly W J, Canick J A. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.  Br J Obstet Gynaecol. 1999;  106 1304-1306
• 36 Ribbert L S, Kornman L H, de Wolf B T et al.. Maternal serum screening for fetal Down syndrome in IVF pregnancies.  Prenat Diagn. 1996;  16 35-38